BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
The EWS/FLI translocation product is the causative oncogene in Ewing sarcoma and acts as an aberrant transcription factor. EWS/FLI dysregulates gene expression during tumorigenesis by abnormally activating or repressing genes. The expression levels of thousands of genes are affected in Ewing sarcoma...
Saved in:
Main Authors: | Elizabeth T Wiles, Bianca Lui-Sargent, Russell Bell, Stephen L Lessnick |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/6116bd5bc3a94646a34c47a8b40bb2a9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
by: Maria E. Gierisch, et al.
Published: (2019) -
A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins
by: Krishna Priya Thangaretnam, et al.
Published: (2017) -
EWS–FLI1‐targeting peptide identifies Ewing sarcoma tumor boundaries and lymph node metastasis via near‐infrared imaging
by: Yu Wang, et al.
Published: (2021) -
Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.
by: Noelia Agra, et al.
Published: (2013) -
Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma.
by: Davis T Weaver, et al.
Published: (2021)